Drug Repositioning: Current Advances and Future Perspectives
Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2019 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (153 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544464804498 |
---|---|
ctrlnum |
(CKB)4920000000094361 (oapen)https://directory.doabooks.org/handle/20.500.12854/45510 (EXLCZ)994920000000094361 |
collection |
bib_alma |
record_format |
marc |
spelling |
Yuhei Nishimura auth Drug Repositioning: Current Advances and Future Perspectives Drug Repositioning Frontiers Media SA 2019 1 electronic resource (153 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process because it takes advantage of drugs already in clinical use for other indications or drugs that have cleared phase I safety trials but have failed to show efficacy in the intended diseases. Historically, drug repositioning has been realized through serendipitous clinical observations or improved understanding of disease mechanisms. However, recent technological advances have enabled a more systematic approach to drug repositioning. This eBook collects 16 articles from 112 authors, providing readers with current advances and future perspectives of drug repositioning. English database Integrative strategies molecular docking polypharmacology multi-omics computational analysis data sharing Patenting 2-88945-696-X Hideaki Hara auth |
language |
English |
format |
eBook |
author |
Yuhei Nishimura |
spellingShingle |
Yuhei Nishimura Drug Repositioning: Current Advances and Future Perspectives Frontiers Research Topics |
author_facet |
Yuhei Nishimura Hideaki Hara |
author_variant |
y n yn |
author2 |
Hideaki Hara |
author2_variant |
h h hh |
author_sort |
Yuhei Nishimura |
title |
Drug Repositioning: Current Advances and Future Perspectives |
title_full |
Drug Repositioning: Current Advances and Future Perspectives |
title_fullStr |
Drug Repositioning: Current Advances and Future Perspectives |
title_full_unstemmed |
Drug Repositioning: Current Advances and Future Perspectives |
title_auth |
Drug Repositioning: Current Advances and Future Perspectives |
title_alt |
Drug Repositioning |
title_new |
Drug Repositioning: Current Advances and Future Perspectives |
title_sort |
drug repositioning: current advances and future perspectives |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2019 |
physical |
1 electronic resource (153 p.) |
isbn |
2-88945-696-X |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT yuheinishimura drugrepositioningcurrentadvancesandfutureperspectives AT hideakihara drugrepositioningcurrentadvancesandfutureperspectives AT yuheinishimura drugrepositioning AT hideakihara drugrepositioning |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094361 (oapen)https://directory.doabooks.org/handle/20.500.12854/45510 (EXLCZ)994920000000094361 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Drug Repositioning: Current Advances and Future Perspectives |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548743342489600 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02022nam-a2200397z--4500</leader><controlfield tag="001">993544464804498</controlfield><controlfield tag="005">20231214132823.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094361</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/45510</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094361</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yuhei Nishimura</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug Repositioning: Current Advances and Future Perspectives</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Drug Repositioning</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (153 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process because it takes advantage of drugs already in clinical use for other indications or drugs that have cleared phase I safety trials but have failed to show efficacy in the intended diseases. Historically, drug repositioning has been realized through serendipitous clinical observations or improved understanding of disease mechanisms. However, recent technological advances have enabled a more systematic approach to drug repositioning. This eBook collects 16 articles from 112 authors, providing readers with current advances and future perspectives of drug repositioning.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">database</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Integrative strategies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular docking</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polypharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multi-omics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">computational analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drug Repositioning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">data sharing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Patenting</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-696-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hideaki Hara</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:32:05 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337632000004498&Force_direct=true</subfield><subfield code="Z">5337632000004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337632000004498</subfield></datafield></record></collection> |